top of page
gradientForSurfBreak.png

Item List

SpinalNews International
COMPaSS personalised spine surgery study begins enrolment

Carlsmed has revealed that the first patients have been enrolled in the COMPaSS study, a multicentre post market prospective observational registry which will collect data up to two years on patients with degenerative spinal conditions who are treated surgically with the company’s aprevo devices.

Recent Posts

Portfolio Company

Carlsmed.png

Ready. Set. Food! and ObvioHealth Launch Innovative Trial to Correlate Infant Fo ...

PR Newswire

Portfolio Company

Carlsmed.png

Forbes Recognizes Luna as a Top-Rated Employer in its List of America’s Best Emp ...

Yahoo Finance

Portfolio Company

Carlsmed.png

xCures: Empowering Healthcare Researchers To Deeply Understand Each Patient’s Me ...

Pulse 2.0

surf break copy_edited_edited.jpg
surbreak-19.png
WM360_logo-18.png
bottom of page